Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Utility of atherosclerosis imaging in the evaluation of high-density lipoprotein-raising therapies Duivenvoorden R; Fayad ZACurr Atheroscler Rep 2011[Jun]; 13 (3): 277-84Decreased level of high density-lipoprotein cholesterol (HDL-C) is a rigorous predictor for future cardiovascular events. Much effort is being made to develop HDL-C-raising pharmacotherapies in the attempt to avert the pandemic of atherosclerotic disease. Important properties by which HDL-C-raising compounds are effective involve improvement of cholesterol uptake from macrophages in plaque for transport back to the liver, improvement of endothelial function, and anti-inflammatory effects. Vascular imaging can aid in the determination which HDL-C-raising compounds are effective. Ultrasound and MRI have proved suitable for assessment of structural changes of the vessel wall. Ultrasound can also be used or assessment of endothelial function. 18F-fluordeoxyglucose positron emission tomography has opened up the possibility to assess vessel wall inflammation. In this article we discuss these various imaging techniques and how they can assess efficacy as well as provide pathophysiologic information on the mechanism of action of novel HDL-C-raising drugs.|*Hypolipidemic Agents/pharmacokinetics/standards/therapeutic use[MESH]|Carotid Arteries/*pathology[MESH]|Cholesterol, HDL/*metabolism[MESH]|Drug Monitoring/*methods[MESH]|Endothelium, Vascular/drug effects/metabolism/pathology[MESH]|Humans[MESH]|Lipid Metabolism/*drug effects[MESH]|Magnetic Resonance Imaging[MESH]|Microscopy, Acoustic[MESH]|Pharmacology, Clinical/methods[MESH]|Plaque, Atherosclerotic/complications/*diagnosis/drug therapy/metabolism[MESH]|Positron-Emission Tomography[MESH]|Randomized Controlled Trials as Topic[MESH]|Tunica Intima/pathology[MESH]|Vasodilation/drug effects[MESH] |